The Board of OncoSil Medical Ltd. announced that two key treatment centres have treated their first commercial patients with the OncoSil device. OncoSil has achieved a significant milestone with the first patient treated with the OncoSilTM device in the Middle East. The first patient treatment in Israel has been performed at the Wolfson Medical Center in Tel Aviv, Israel.

They are working with other institutions in Israel to treat patients with the OncoSilTM device. OncoSil is also pleased to announce the first patient treatment at the Clinica Universidad de Navarra, located in Pamplona, Spain. This hospital is considered a leading private hospital in Spain, as well as being an institution which is highly recognised for scientific leadership.

They expect that the addition of this treatment site will enhance the recognition of the OncoSil device as a treatment option across Spain as well as raising the profile across Europe.